 | • レポートコード：D0GIR-04220 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胃食道逆流薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃食道逆流薬の種類別市場規模（エソメプラゾール、ランソプラゾール、オメプラゾール、ルベプラゾール、デキスランソプラゾール、その他）、用途別市場規模（病院、外来手術センター、専門クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Takeda、Jiangsu Aosaikang、Cadila Pharmaceuticals、Altana Pharma、AstraZeneca、Luoxin、Pfizer、Eisai、NCPC ・地域別グローバル市場分析 2015年-2020年 ・胃食道逆流薬の北米市場（アメリカ、カナダ、メキシコ） ・胃食道逆流薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胃食道逆流薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胃食道逆流薬の南米市場（ブラジル、アルゼンチン） ・胃食道逆流薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：エソメプラゾール、ランソプラゾール、オメプラゾール、ルベプラゾール、デキスランソプラゾール、その他 ・用途別分析：病院、外来手術センター、専門クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Gastroesophageal Reflux Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Gastroesophageal Reflux Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Gastroesophageal Reflux Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastroesophageal Reflux Drugs market has been segmented into
Esomeprazole
Lansoprazole
Omeprazole
Rbeprazole
Dexlansoprazole
Others
By Application, Gastroesophageal Reflux Drugs has been segmented into:
Hospitals
Ambulatory surgical centers
Specialty clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastroesophageal Reflux Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastroesophageal Reflux Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastroesophageal Reflux Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Gastroesophageal Reflux Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastroesophageal Reflux Drugs Market Share Analysis
Gastroesophageal Reflux Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastroesophageal Reflux Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastroesophageal Reflux Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Gastroesophageal Reflux Drugs are:
Bayer
Takeda
Jiangsu Aosaikang
Cadila Pharmaceuticals
Altana Pharma
AstraZeneca
Luoxin
Pfizer
Eisai
NCPC
Among other players domestic and global, Gastroesophageal Reflux Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastroesophageal Reflux Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastroesophageal Reflux Drugs, with price, sales, revenue and global market share of Gastroesophageal Reflux Drugs in 2018 and 2019.
Chapter 3, the Gastroesophageal Reflux Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastroesophageal Reflux Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastroesophageal Reflux Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastroesophageal Reflux Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gastroesophageal Reflux Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastroesophageal Reflux Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Esomeprazole
1.2.3 Lansoprazole
1.2.4 Omeprazole
1.2.5 Rbeprazole
1.2.6 Dexlansoprazole
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastroesophageal Reflux Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory surgical centers
1.3.4 Specialty clinics
1.3.5 Others
1.4 Overview of Global Gastroesophageal Reflux Drugs Market
1.4.1 Global Gastroesophageal Reflux Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Jiangsu Aosaikang
2.3.1 Jiangsu Aosaikang Details
2.3.2 Jiangsu Aosaikang Major Business
2.3.3 Jiangsu Aosaikang SWOT Analysis
2.3.4 Jiangsu Aosaikang Product and Services
2.3.5 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cadila Pharmaceuticals
2.4.1 Cadila Pharmaceuticals Details
2.4.2 Cadila Pharmaceuticals Major Business
2.4.3 Cadila Pharmaceuticals SWOT Analysis
2.4.4 Cadila Pharmaceuticals Product and Services
2.4.5 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Altana Pharma
2.5.1 Altana Pharma Details
2.5.2 Altana Pharma Major Business
2.5.3 Altana Pharma SWOT Analysis
2.5.4 Altana Pharma Product and Services
2.5.5 Altana Pharma Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Product and Services
2.6.4 AstraZeneca Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Luoxin
2.7.1 Luoxin Details
2.7.2 Luoxin Major Business
2.7.3 Luoxin Product and Services
2.7.4 Luoxin Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Product and Services
2.9.4 Eisai Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Product and Services
2.10.4 NCPC Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastroesophageal Reflux Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastroesophageal Reflux Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastroesophageal Reflux Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Gastroesophageal Reflux Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastroesophageal Reflux Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Gastroesophageal Reflux Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastroesophageal Reflux Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
4.5 South America Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastroesophageal Reflux Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Gastroesophageal Reflux Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastroesophageal Reflux Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastroesophageal Reflux Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Gastroesophageal Reflux Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastroesophageal Reflux Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
6.3 UK Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
6.4 France Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastroesophageal Reflux Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastroesophageal Reflux Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastroesophageal Reflux Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
7.5 India Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastroesophageal Reflux Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Gastroesophageal Reflux Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastroesophageal Reflux Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastroesophageal Reflux Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastroesophageal Reflux Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastroesophageal Reflux Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastroesophageal Reflux Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Gastroesophageal Reflux Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Gastroesophageal Reflux Drugs Price by Type (2015-2020)
11 Global Gastroesophageal Reflux Drugs Market Segment by Application
11.1 Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2015-2020)
11.2 Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Gastroesophageal Reflux Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastroesophageal Reflux Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastroesophageal Reflux Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Gastroesophageal Reflux Drugs Market Forecast (2021-2025)
12.2.2 Europe Gastroesophageal Reflux Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastroesophageal Reflux Drugs Market Forecast (2021-2025)
12.2.4 South America Gastroesophageal Reflux Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastroesophageal Reflux Drugs Market Forecast (2021-2025)
12.3 Gastroesophageal Reflux Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Gastroesophageal Reflux Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Gastroesophageal Reflux Drugs Market Share Forecast by Type (2021-2025)
12.4 Gastroesophageal Reflux Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Gastroesophageal Reflux Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Gastroesophageal Reflux Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gastroesophageal Reflux Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastroesophageal Reflux Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastroesophageal Reflux Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Gastroesophageal Reflux Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Gastroesophageal Reflux Drugs Major Business
Table 10. Bayer Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Bayer SWOT Analysis
Table 12. Bayer Gastroesophageal Reflux Drugs Product and Services
Table 13. Bayer Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Takeda Basic Information, Manufacturing Base and Competitors
Table 15. Takeda Gastroesophageal Reflux Drugs Major Business
Table 16. Takeda Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Takeda SWOT Analysis
Table 18. Takeda Gastroesophageal Reflux Drugs Product and Services
Table 19. Takeda Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Jiangsu Aosaikang Basic Information, Manufacturing Base and Competitors
Table 21. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Major Business
Table 22. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Jiangsu Aosaikang SWOT Analysis
Table 24. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Product and Services
Table 25. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 27. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Major Business
Table 28. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Cadila Pharmaceuticals SWOT Analysis
Table 30. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Product and Services
Table 31. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Altana Pharma Basic Information, Manufacturing Base and Competitors
Table 33. Altana Pharma Gastroesophageal Reflux Drugs Major Business
Table 34. Altana Pharma Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Altana Pharma SWOT Analysis
Table 36. Altana Pharma Gastroesophageal Reflux Drugs Product and Services
Table 37. Altana Pharma Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Gastroesophageal Reflux Drugs Major Business
Table 40. AstraZeneca Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 41. AstraZeneca SWOT Analysis
Table 42. AstraZeneca Gastroesophageal Reflux Drugs Product and Services
Table 43. AstraZeneca Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Luoxin Basic Information, Manufacturing Base and Competitors
Table 45. Luoxin Gastroesophageal Reflux Drugs Major Business
Table 46. Luoxin Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 47. Luoxin SWOT Analysis
Table 48. Luoxin Gastroesophageal Reflux Drugs Product and Services
Table 49. Luoxin Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Pfizer Basic Information, Manufacturing Base and Competitors
Table 51. Pfizer Gastroesophageal Reflux Drugs Major Business
Table 52. Pfizer Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Pfizer SWOT Analysis
Table 54. Pfizer Gastroesophageal Reflux Drugs Product and Services
Table 55. Pfizer Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Eisai Basic Information, Manufacturing Base and Competitors
Table 57. Eisai Gastroesophageal Reflux Drugs Major Business
Table 58. Eisai Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 59. Eisai SWOT Analysis
Table 60. Eisai Gastroesophageal Reflux Drugs Product and Services
Table 61. Eisai Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. NCPC Basic Information, Manufacturing Base and Competitors
Table 63. NCPC Gastroesophageal Reflux Drugs Major Business
Table 64. NCPC Gastroesophageal Reflux Drugs Total Revenue (USD Million) (2018-2019)
Table 65. NCPC SWOT Analysis
Table 66. NCPC Gastroesophageal Reflux Drugs Product and Services
Table 67. NCPC Gastroesophageal Reflux Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Gastroesophageal Reflux Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 69. Global Gastroesophageal Reflux Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Gastroesophageal Reflux Drugs Sales by Regions (2015-2020) (K Units)
Table 71. Global Gastroesophageal Reflux Drugs Sales Market Share by Regions (2015-2020)
Table 72. Global Gastroesophageal Reflux Drugs Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Gastroesophageal Reflux Drugs Sales by Countries (2015-2020) (K Units)
Table 74. North America Gastroesophageal Reflux Drugs Sales Market Share by Countries (2015-2020)
Table 75. North America Gastroesophageal Reflux Drugs Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Gastroesophageal Reflux Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Gastroesophageal Reflux Drugs Sales by Countries (2015-2020) (K Units)
Table 78. Europe Gastroesophageal Reflux Drugs Sales Market Share by Countries (2015-2020)
Table 79. Europe Gastroesophageal Reflux Drugs Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Gastroesophageal Reflux Drugs Sales by Regions (2015-2020) (K Units)
Table 81. Asia-Pacific Gastroesophageal Reflux Drugs Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Gastroesophageal Reflux Drugs Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Gastroesophageal Reflux Drugs Sales by Countries (2015-2020) (K Units)
Table 84. South America Gastroesophageal Reflux Drugs Sales Market Share by Countries (2015-2020)
Table 85. South America Gastroesophageal Reflux Drugs Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Gastroesophageal Reflux Drugs Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Gastroesophageal Reflux Drugs Sales by Countries (2015-2020) (K Units)
Table 88. Middle East & Africa Gastroesophageal Reflux Drugs Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Gastroesophageal Reflux Drugs Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Gastroesophageal Reflux Drugs Revenue Market Share by Countries (2015-2020)
Table 91. Global Gastroesophageal Reflux Drugs Sales by Type (2015-2020) (K Units)
Table 92. Global Gastroesophageal Reflux Drugs Sales Share by Type (2015-2020)
Table 93. Global Gastroesophageal Reflux Drugs Revenue by Type (2015-2020) (USD Million)
Table 94. Global Gastroesophageal Reflux Drugs Revenue Share by Type (2015-2020)
Table 95. Global Gastroesophageal Reflux Drugs Sales by Application (2015-2020) (K Units)
Table 96. Global Gastroesophageal Reflux Drugs Sales Share by Application (2015-2020)
Table 97. Global Gastroesophageal Reflux Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 98. Global Gastroesophageal Reflux Drugs Market Share Forecast by Regions (2021-2025)
Table 99. Global Gastroesophageal Reflux Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 100. Global Gastroesophageal Reflux Drugs Market Share Forecast by Type (2021-2025)
Table 101. Global Gastroesophageal Reflux Drugs Sales Forecast by Application (2021-2025)
Table 102. Global Gastroesophageal Reflux Drugs Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastroesophageal Reflux Drugs Picture
Figure 2. Global Sales Market Share of Gastroesophageal Reflux Drugs by Type in 2019
Figure 3. Esomeprazole Picture
Figure 4. Lansoprazole Picture
Figure 5. Omeprazole Picture
Figure 6. Rbeprazole Picture
Figure 7. Dexlansoprazole Picture
Figure 8. Others Picture
Figure 9. Gastroesophageal Reflux Drugs Sales Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Ambulatory surgical centers Picture
Figure 12. Specialty clinics Picture
Figure 13. Others Picture
Figure 14. Global Gastroesophageal Reflux Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Gastroesophageal Reflux Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Gastroesophageal Reflux Drugs Sales Market Share by Manufacturer in 2019
Figure 35. Global Gastroesophageal Reflux Drugs Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Gastroesophageal Reflux Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Gastroesophageal Reflux Drugs Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 40. Global Gastroesophageal Reflux Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Gastroesophageal Reflux Drugs Revenue Market Share by Regions (2015-2020)
Figure 42. Global Gastroesophageal Reflux Drugs Revenue Market Share by Regions in 2018
Figure 43. North America Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
Figure 44. Europe Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
Figure 46. South America Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020)
Figure 48. North America Gastroesophageal Reflux Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Gastroesophageal Reflux Drugs Sales Market Share by Countries (2015-2020)
Figure 50. North America Gastroesophageal Reflux Drugs Sales Market Share by Countries in 2018
Figure 51. North America Gastroesophageal Reflux Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Gastroesophageal Reflux Drugs Revenue Market Share by Countries in 2018
Figure 53. United States Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Canada Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Mexico Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Europe Gastroesophageal Reflux Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Gastroesophageal Reflux Drugs Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Gastroesophageal Reflux Drugs Revenue Market Share by Countries in 2019
Figure 59. Germany Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. UK Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. France Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Russia Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Italy Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Asia-Pacific Gastroesophageal Reflux Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Gastroesophageal Reflux Drugs Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Gastroesophageal Reflux Drugs Revenue Market Share by Regions 2019
Figure 67. China Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Japan Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Korea Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. India Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Southeast Asia Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. South America Gastroesophageal Reflux Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Gastroesophageal Reflux Drugs Sales Market Share by Countries in 2019
Figure 74. South America Gastroesophageal Reflux Drugs Revenue Market Share by Countries in 2019
Figure 75. Brazil Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Argentina Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Middle East and Africa Gastroesophageal Reflux Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Gastroesophageal Reflux Drugs Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Gastroesophageal Reflux Drugs Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Gastroesophageal Reflux Drugs Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Egypt Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Turkey Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. South Africa Gastroesophageal Reflux Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Global Gastroesophageal Reflux Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 86. Global Gastroesophageal Reflux Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Gastroesophageal Reflux Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Europe Sales Gastroesophageal Reflux Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Asia-Pacific Sales Gastroesophageal Reflux Drugs Market Forecast (2021-2025) (K Units)
Figure 90. South America Sales Gastroesophageal Reflux Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Middle East & Africa Sales Gastroesophageal Reflux Drugs Market Forecast (2021-2025) (K Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
胃食道逆流症（GERD）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4989.6 million by 2025, from USD 4870.2 milli…- 逆流試験・監視装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Reflux Testing and Monitoring Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Reflux …
- 逆流性腎症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Reflux Nephropathy Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Reflux Nephropat…
- デキスランソプラゾールの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Dexlansoprazole market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- コンパニオンアニマル用専門薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Companion Animal Specialty Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Companion An…